Timothy Trysla on Medical Devices

Health Care Week in Review: FDA Released Its User Fee Amendments For FY 2023

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

10/10/2022 / Biosimilars , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Federal Food Drug and Cosmetic Act (FFDCA) , Food and Drug Administration (FDA) , Health Care Providers , Healthcare Facilities , HRSA , Medical Devices , National Institute of Health (NIH) , User Fees , Vaccinations

Health Care Week in Review: HHS Declared a Public Health Emergency (PHE) for Puerto Rico Due to the Flooding

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

9/27/2022 / Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Healthcare Facilities , Medicaid , Medical Devices , Nursing Homes , OIG , Popular , Public Health Emergency

Health Care Week in Review: The Inflation Reduction Act of 2022 Becomes Law

Below is Alston & Bird's Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

8/22/2022 / Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Children's Health Insurance Program (CHIP) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Inflation Reduction Act (IRA) , Medicaid , Medical Devices , Prescription Drugs

Health Care Week in Review: CMS Released a 2022 Strategic Framework White Paper and Year in Review Report

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

6/13/2022 / Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medical Devices , Medicare

Health Care Week in Review: The Medicare Trustees Released a Report Projecting Medicare Would Remain Solvent Until 2028

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

6/6/2022 / Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medicaid , Medical Devices , Medicare

Alston & Bird Health Care Week in Review - May 2022 #1

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

5/9/2022 / Centers for Disease Control and Prevention (CDC) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Investigational New Drug Application (IND) , Medicaid , Medical Devices , Medicare , Pharmaceutical Industry , Popular , Prescription Drugs , Telehealth , Vaccinations

Alston & Bird Health Care Week in Review - April 2022 #3

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

4/18/2022 / Abbreviated New Drug Application (ANDA) , Advisory Board , CBO Report , Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Final Guidance , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Information Reports , Medical Devices , National Institute of Health (NIH) , Popular , Prescription Drugs , Proposed Rules , Public Meetings , Public Policy

Alston & Bird Health Care Week in Review - January 2022 #3

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

1/24/2022 / Centers for Medicare & Medicaid Services (CMS) , Clinical Laboratories , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medicaid , Medical Devices , Medicare , Proposed Rules , Public Policy , Vaccinations

Alston & Bird Health Care Week in Review - October 2021 #4

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

10/25/2021 / Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medical Devices , Pharmaceutical Industry , Prescription Drugs

Alston & Bird Health Care Week in Review - September 2020 #4

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

9/28/2020 / Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Health Care Providers , Hospitals , Medicaid , Medical Devices , Medicare , Trump Administration , Vaccinations

Alston & Bird Health Care Week in Review - September 2020 #2

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

9/14/2020 / Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Hospitals , Medicaid , Medical Devices , Medical Testing , Medicare , Vaccinations

Alston & Bird Health Care Week in Review - September 2020 #1

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

9/8/2020 / Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Health Care Providers , Health Insurance , Hospitals , Medicaid , Medical Devices , Medical Testing , Medicare , Physicians , Public Health , Public Health Emergency , Vaccinations , Virus Testing

Alston & Bird Health Care Week in Review - August 2020 #2

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and...more

8/17/2020 / Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Clinical Trials , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medicaid , Medical Devices , Medicare , Pharmaceutical Industry , Rural Health Care Providers , SAMHSA